Suzuki Hayabusa recalled in India: Here’s why

Whenever someone thinks of a superbike, inevitably the image of a Hayabusa pops into our minds. It won’t be wrong to say Suzuki Hayabusa is the universal epitome of performance on two wheels. Suzuki has now issued a service recall of some units of the burly sports tourer in India.

A recent media report states that the Japanese auto giant has recalled 1056 units of the Busa in India which have been manufactured between March 2021 and September 2024. This means most units, if not all, bought during the above-mentioned period have to undergo this recall.

Suzuki Hayabusa (Image: Suzuki)

The reason given for this recall is that the play in the front brake lever increases and in worst cases, the lever even contacts the throttle grip which may result in an increase in braking distance. This suggests that the front brake lever play can get excessive to the point that the lever may come in contact with the throttle grip which could lead to an unforeseen situation. Speaking of braking, the third-gen Hayabusa gets 320mm front and 260mm rear disc brakes with Brembo Stylema callipers.

Also Read Dhanteras: Nearly 30% surge already in past 1 year! Gold to cross Rs 1 lakh mark by next Diwali? Hyundai India IPO subscribed 42 per cent on Day 2 Hyundai Motor India IPO: GMP falls 54% in last one week China, valuation woes keep Indian equities under pressure

Also Read2025 Yamaha MT-07 unveiled — Gets major updates

As of now, there is no official information from Suzuki about the exact fix for this issue or an exact timeline for this recall exercise. Owners of the Busa can check if their bike is among those recalled by entering the VIN on Suzuki’s official website. Powering the Hayabusa is a 1340cc, four-cylinder, liquid-cooled engine which pumps out 190 bhp and 150 Nm of peak torque. This motor is paired with a six-speed gearbox equipped with a bi-directional quickshifter.

Source: Autocar India

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth